Marie Wikström Lindholm
Technik-/Wissenschafts-/F&E-Leiter bei SILENCE THERAPEUTICS PLC
Profil
Marie Wikström Lindholm is currently the Director at Oligonucleotide Therapeutics Society, Inc. since 2022.
She is also the Chief Scientific Officer at Silence Therapeutics Plc since 2017.
Previously, she worked as an Assistant Professor at the University of Lund from 1999 to 2000.
Dr. Lindholm holds a doctorate degree from the University of Uppsala.
Aktive Positionen von Marie Wikström Lindholm
| Unternehmen | Position | Beginn |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2023 |
Oligonucleotide Therapeutics Society, Inc.
 Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The private company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Direktor/Vorstandsmitglied | 18.01.2022 |
Ehemalige bekannte Positionen von Marie Wikström Lindholm
| Unternehmen | Position | Ende |
|---|---|---|
| University of Lund | Corporate Officer/Principal | 01.01.2000 |
Ausbildung von Marie Wikström Lindholm
| University of Uppsala | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SILENCE THERAPEUTICS PLC | Commercial Services |
| Private Unternehmen | 1 |
|---|---|
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beckman Research Institute of The City of Hope, Oligonucleotide Therapeutics Society, Inc. is a society that envisions a new era of oligonucleotide drugs that would change the landscape of therapeutic modalities. The private company is based in San Diego, CA. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. The society offers various awards to support the accomplishments of students, postdocs, and young investigators. | Commercial Services |
